HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, July 6, 2017 (HealthDay News) -- Sleep quality is associated with risk of Alzheimer's disease (AD), according to research published online July 5 in Neurology.
The study included 101 people and their average age was 63. At the time of testing, all of the study volunteers had normal cognitive and memory skills but were considered at risk for AD either because they had a parent with the disease or they carried the apolipoprotein E (APOE) gene. The study volunteers gave a sample of spinal fluid to be tested for markers of AD, and answered questions to assess the quality of their sleep.
The researchers found an association between greater AD pathology and worse subjective sleep quality, more sleep problems, and daytime somnolence. The pathology was demonstrated by lower cerebral spinal fluid β-amyloid 42/β-amyloid 40 (Aβ42/Aβ40) and higher total tau/Aβ42, phosphorylated tau/Aβ42, monocyte chemoattractant protein 1/Aβ42, and chitinase-3-like protein 1/Aβ42. The team found no significant associations between sleep and neurofilament light or neurogranin.
"This study and others in the field suggest that sleep may be a modifiable risk factor for Alzheimer's disease," senior researcher Barbara Bendlin, Ph.D., an associate professor of medicine at the University of Wisconsin School of Medicine and Public Health in Madison, told HealthDay. "This will require studies that directly test whether modifying sleep has a beneficial effect on the brain."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 29, 2022